Topic
specialty pharmacy data
Articles tagged specialty pharmacy data.
16 articles
NDC Product Hierarchy in Pharma: Why a Dose Change Shows Up as a Lost Patient, and How to Fix It
Why specialty brand reports read a dose step-up as a stopped patient, and how an NDC product hierarchy keeps patient counts, persistence and units honest.
NBRx vs NRx vs New Patient Starts: Which New Patient Number Your Specialty Brand Should Trust
How NRx, NBRx and new patient starts differ, why they disagree for specialty brands, and the data rules that make one new patient number hold up.
PDC vs MPR in Specialty Pharma: Which Adherence Measure to Trust, and the Data Rules Behind It
How PDC and MPR measure adherence, why MPR can read above 100 percent, and the data rules specialty brands need before trusting either number.
Payer Hierarchy in Pharma: How to Map Plans, PBMs and Channels So Access Reporting Holds Up
Why the same payer appears under many names across hub, SP and claims data, and how to build a payer hierarchy access and commercial leaders can trust.
Therapy Discontinuation Reasons in Specialty Pharma: Why "Other" Is Your Biggest Category, and How to Fix the Reason Codes
Why discontinuation reasons from hubs and specialty pharmacies end up as other or unknown, and how to build a reason model leaders can act on.
Specialty Pharmacy Data Aggregator: How to Choose One, and When You Do Not Need One
How to choose a specialty pharmacy data aggregator: what it should cover, an RFP scorecard, aggregator vs in-house, data agreement terms and costly mistakes.
Pharma Launch Analytics: Metrics, Data and a 20-Week Build Plan
Pharma launch analytics for specialty brands: the metrics that matter, which data answers each, costs, a 20-week build plan and when not to buy a platform.
Active Patient Definition in Specialty Pharma: The Rules Behind the Number on Your Dashboard
How to define an active patient in specialty pharma: grace periods, days supply, as-of dates, transfers and free drug, and why each rule moves the count.
Specialty Pharmacy Status Codes: How to Map SP and Hub Statuses Into One Patient Status Model
Every specialty pharmacy and hub sends its own status codes. How to map them into one patient status model leadership can read and act on.
Pharma Commercial Data Warehouse: How to Build, Buy or Outsource One
A buyer's guide to the pharma commercial data warehouse: the data feeds, build vs buy vs managed, launch timelines, cost drivers and an RFP checklist.
Patient Tokenization in Specialty Pharma: What It Links, What It Cannot, and What to Check
How patient tokens link hub, specialty pharmacy and claims data without sharing identities, where matches fail, and what leaders should check.
Automating the Weekly Patient Services Report: Why It Is Still Rebuilt by Hand, and How to Stop
Why the weekly hub and specialty pharmacy report is still rebuilt by hand in specialty pharma, what it costs, and how to automate it in five steps.
Prescription Abandonment vs Reversal in Specialty Pharma: Definitions That Hold Up in a QBR
Abandonment, reversal, rejection and discontinuation are four different events. How to define and measure each from SP, hub and claims data.
Patient Access KPIs
This is where Patient Access KPIs (Key Performance Indicators) become essential. A well designed KPI set helps Market Access, Patient Services, and Commercial teams monitor the health of the...
What Specialty Pharmacy Data Is and How Pharma Should Use It
In the ecosystem of patient access, specialty pharmacies are essential. Prescription intake, benefits verification, prior authorization coordination, dispensing, refills, and adherence support are...
Patient Access Dashboards: KPIs to Track Time to Therapy and Conversions
Patient Access Dashboards: KPIs to Track Time to Therapy and Conversions In today’s healthcare landscape where patient experience, treatment speed, and operational efficiency matter more than ever...
Related topics